MBCL-43. RECURRENT MEDULLOBLASTOMA – LONG-TERM SURVIVAL WITH A “MEMMAT” BASED ANTIANGIOGENIC APPROACH

INTRODUCTION: Patients with recurrent medulloblastoma have a poor prognosis with only around 8% of patients surviving at 5 years irrespective of salvage therapy used. We report on 29 patients from four institutions treated with a “MEMMAT” based antiangiogenic combination therapy. PATIENTS AND METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Slavc, Irene, Peyrl, Andreas, Gojo, Johannes, Holm, Stefan, Blomgren, Klas, Sehested, Astrid M, Leblond, Pierre, Czech, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Medulloblastoma (Clinical)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715695/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.516
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados